Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p.

Topoisomerase I (Top1) relaxes DNA supercoiling by forming transient cleavage complexes (Top1cc) up- and downstream of transcription complexes. Top1cc can be trapped by carcinogenic and endogenous DNA lesions and by camptothecin, resulting in transcription blocks. Here, we undertook genome-wide analysis of camptothecin-treated cells at exon resolution. RNA samples from HCT116 and MCF7 cells were analyzed with the Affy Exon Array platform, allowing high-resolution mapping along 18,537 genes. Long genes that are highly expressed were the most susceptible to downregulation, whereas short genes were preferentially upregulated. Along the body of genes, downregulation was most important toward the 3'-end and increased with the number of exon-intron junctions. Ubiquitin and RNA degradation-related pathway genes were selectively downregulated. Parallel analysis of microRNA with the Agilent miRNA microarray platform revealed that miR-142-3p was highly induced by camptothecin. More than 10% of the downregulated genes were targets of this p53-dependent microRNA. Our study shows the profound impact of Top1cc on transcription elongation, especially at intron-exon junctions and on transcript stability by microRNA miR-142-3p upregulation.

[1]  Jian Jin,et al.  Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons , 2011, Nature.

[2]  Bing Su,et al.  Small but influential: the role of microRNAs on gene regulatory network and 3'UTR evolution. , 2009, Journal of genetics and genomics = Yi chuan xue bao.

[3]  L. Liu,et al.  Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. , 1989, Cancer research.

[4]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[5]  JAMES C. Wang,et al.  Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.

[6]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[7]  Elisa Izaurralde,et al.  Deadenylation is a widespread effect of miRNA regulation. , 2008, RNA.

[8]  Y. Pommier,et al.  Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I. , 2003, Cancer research.

[9]  Hui Zhang,et al.  Transcription-Dependent Degradation of Topoisomerase I-DNA Covalent Complexes , 2003, Molecular and Cellular Biology.

[10]  K. Kohn,et al.  Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells. , 1972, Molecular pharmacology.

[11]  A. Pries,et al.  Cdc2-Like Kinases and DNA Topoisomerase I Regulate Alternative Splicing of Tissue Factor in Human Endothelial Cells , 2009, Circulation research.

[12]  Gregory J. Hannon,et al.  microRNAs join the p53 network — another piece in the tumour-suppression puzzle , 2007, Nature Reviews Cancer.

[13]  K. Taira,et al.  MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells. , 2004, Nucleic acids symposium series.

[14]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[15]  P. Sharp,et al.  Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription. , 1997, Genes & development.

[16]  L. Corcos,et al.  PKC zeta controls DNA topoisomerase‐dependent human caspase‐2 pre‐mRNA splicing , 2008, FEBS letters.

[17]  P. Meltzer,et al.  CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute , 2012, Oncogene.

[18]  Y. Pommier,et al.  The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA–topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts , 2008, Nucleic acids research.

[19]  Francesca Ferri,et al.  Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells. , 2006, Journal of molecular biology.

[20]  Y. Pommier,et al.  Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication Runoff , 2000, Molecular and Cellular Biology.

[21]  J. Tazi,et al.  Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I , 1996, Nature.

[22]  Y. Pommier,et al.  DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1α gene locus , 2009, Nucleic acids research.

[23]  A. Tomida,et al.  Cullin 3 Promotes Proteasomal Degradation of the Topoisomerase I-DNA Covalent Complex , 2004, Cancer Research.

[24]  L. Corcos,et al.  Nonsense-mediated mRNA decay among human caspases: the caspase-2S putative protein is encoded by an extremely short-lived mRNA , 2005, Cell Death and Differentiation.

[25]  L. Liu,et al.  Processing of topoisomerase I cleavable complexes into DNA damage by transcription. , 1997, Nucleic acids research.

[26]  Y. Pommier,et al.  Repair of topoisomerase I-mediated DNA damage. , 2006, Progress in nucleic acid research and molecular biology.

[27]  M. Chaudhry,et al.  Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways. , 2010, DNA and cell biology.

[28]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[29]  Y. Pommier.  DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition. , 2009, Chemical reviews.

[30]  Y. Pommier.  DNA Topoisomerases and Cancer , 2012 .

[31]  William C Reinhold,et al.  Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. , 2002, Cancer research.

[32]  G. Chillemi,et al.  A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors. , 2009, European journal of pharmacology.

[33]  L. Corcos,et al.  Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells. , 2004, Molecular cancer research : MCR.

[34]  Y. Pommier.  Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.

[35]  Sherif Abou Elela,et al.  Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes , 2008, Molecular Cancer Therapeutics.

[36]  R. Roeder,et al.  Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Champoux.  DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.

[38]  Xin Zhang,et al.  p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. , 2008, Cancer research.

[39]  P. Hanawalt,et al.  The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcription. , 1996, Carcinogenesis.

[40]  Jing Chen,et al.  Dissecting microregulation of a master regulatory network , 2008, BMC Genomics.

[41]  Felicie F. Andersen,et al.  The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation. , 2002, Journal of molecular biology.

[42]  M. Gaestel,et al.  p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication , 2010, Proceedings of the National Academy of Sciences.

[43]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[44]  Hiroshi I. Suzuki,et al.  Modulation of microRNA processing by p53 , 2009, Nature.

[45]  Y. Pommier,et al.  The Intra-S-Phase Checkpoint Affects both DNA Replication Initiation and Elongation: Single-Cell and -DNA Fiber Analyses , 2007, Molecular and Cellular Biology.

[46]  Aimee L Jackson,et al.  Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. , 2008, Cancer research.

[47]  Y. Pommier,et al.  Hyperphosphorylation of RNA polymerase II in response to topoisomerase I cleavage complexes and its association with transcription- and BRCA1-dependent degradation of topoisomerase I. , 2008, Journal of molecular biology.

[48]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[49]  Michael C. Ryan,et al.  Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors. , 2010, Cancer research.

[50]  M Ahmad Chaudhry,et al.  Real-time PCR analysis of micro-RNA expression in ionizing radiation-treated cells. , 2009, Cancer biotherapy & radiopharmaceuticals.